Pinnacle Wealth Management Advisory Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Pinnacle Wealth Management Advisory Group, LLC
- $1.3 Billion
- Q3 2025
A detailed history of Pinnacle Wealth Management Advisory Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pinnacle Wealth Management Advisory Group, LLC holds 1,527 shares of REGN stock, worth $884,652. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,527
Previous 1,294
18.01%
Holding current value
$884,652
Previous $679,000
26.36%
% of portfolio
0.07%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding REGN
# of Institutions
1,433Shares Held
88.8MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.46 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.89 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.28 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.8 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.22 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...